Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DBVT
DBVT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DBVT News
DBV Tech Advances BLA Submission for VIASKIN Peanut Patch
3d ago
Newsfilter
DBV Technologies Releases FY 2025 Financial Results
3d ago
seekingalpha
DBV Technologies Files 2025 Annual Report and URD
4d ago
Newsfilter
DBV Technologies to Participate in March Investor Conferences
Mar 04 2026
Newsfilter
Total Voting Rights and Shares as of February 28, 2026
Mar 03 2026
Newsfilter
DBV Technologies' VIASKIN Peanut Patch Achieves Phase 3 Trial Success
Mar 02 2026
NASDAQ.COM
DBV Technologies Presents Positive Data from VIASKIN® Peanut Patch Study
Feb 28 2026
Newsfilter
DBV Technologies to Present VIASKIN® Data at AAAAI 2026
Feb 10 2026
Newsfilter
DBV Technologies to Participate in Biotech Summit
Feb 09 2026
Newsfilter
Total Voting Rights and Shares as of January 31, 2026
Feb 05 2026
Newsfilter
DBV Technologies Secures €166.7 Million Financing to Support VIASKIN® Peanut Patch Launch
Jan 16 2026
Globenewswire
DBV Technologies Secures €166.7 Million Financing to Support VIASKIN® Peanut Patch Launch
Jan 16 2026
Newsfilter
Worthington Steel (WS) Enters Acquisition Agreement with Kloeckner & Co, Shares Surge 6.9%
Jan 16 2026
Benzinga
Palvella Therapeutics Stock Soars to $114.69 Following Pipeline Developments
Dec 31 2025
NASDAQ.COM
Biotech Stocks Surge in 2025 with $30.9 Billion M&A Wave
Dec 31 2025
Benzinga
DBV Technologies Advances Peanut Allergy Treatment, Plans BLA Submission in 2026
Dec 28 2025
Benzinga
Show More News